<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01924104</url>
  </required_header>
  <id_info>
    <org_study_id>JJH2013</org_study_id>
    <nct_id>NCT01924104</nct_id>
  </id_info>
  <brief_title>Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.</brief_title>
  <official_title>Effects of Low Dose Aspirin and Low Molecular Weight Heparin Cotreatment, Alone and/or in Combination on Implantation and Clinical Pregnancy Rates in Repeated Implantation Failures in IVF Cycle.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr.Vandana Bansal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jeevan Jyoti Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether low-dose aspirin and low molecular weight
      heparin improve the implantation and pregnancy rates in patients with repeated implantation
      failures in IVF cycle.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that cotreatment of low dose aspirin &amp; low molecular weight
      heparin may improve implantation &amp; clinical pregnancy rates.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biological pregnancy test</measure>
    <time_frame>14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fetal heart/Gestational sac</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come</condition>
  <arm_group>
    <arm_group_label>Low Molecular Weight Heparin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low molecular weight heparin, 2500 milli-International unit/day, subcutaneously</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose aspirin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low dose aspirin, 75mg/day, orally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heparin &amp; Aspirin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Heparin (40 mg/day, subcutaneously) and aspirin (70 mg/day, orally)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium chloride (NaCl)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Equivalent volume of NaCl 0.9%, subcutaneously</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low molecular weight heparin</intervention_name>
    <description>2500 mIU/day, subcutaneously</description>
    <arm_group_label>Low Molecular Weight Heparin</arm_group_label>
    <other_name>LMWH</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low dose aspirin</intervention_name>
    <description>75 mg/day, orally</description>
    <arm_group_label>Low dose aspirin</arm_group_label>
    <other_name>Ecoaspirin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Heparin &amp; aspirin</intervention_name>
    <description>Aspirin (70 mg/day, orally) &amp; heparin (40 mg/day, subcutaneously)</description>
    <arm_group_label>Heparin &amp; Aspirin</arm_group_label>
    <other_name>LMWH &amp; Ecoaspirin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NaCl</intervention_name>
    <description>Equivalent volume of NaCl 0.9%, subcutaneously</description>
    <arm_group_label>Sodium chloride (NaCl)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged between 19 to 35 years;

          -  Basal follicle-stimulating hormone (FSH) levels of ≤8 IU/l

          -  Body mass index (BMI) between 19 kg/m2 and 25 kg/m2

          -  Presence of both ovaries; ≥2 previous IVF failures

          -  Good quality embryos for transfer

          -  Endometrial thickness between 10 mm and 14 mm

        Exclusion Criteria:

          -  Polycystic ovary syndrome

          -  Endometriosis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vandana Bansal, MS DGO PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arpit Test Tube Baby Centre, Vandana Women's Hospital, Jeevan Jyoti Hospital &amp; Research Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vandana Bansal, MS DGO PhD</last_name>
    <phone>+91-0532-2417252</phone>
    <phone_ext>402</phone_ext>
    <email>bansal.drvandana@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ashwani K Bansal, MS</last_name>
    <phone>+91-0532-2417252</phone>
    <phone_ext>403</phone_ext>
    <email>arpitivf@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arpit Test Tube Baby Centre, Jeevan Jyoti Hospital &amp; Research Centre</name>
      <address>
        <city>Allahabad</city>
        <state>Uttar Pradesh</state>
        <zip>211003</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vandana Bansal, MS DGO PhD</last_name>
      <phone>+91-0532-2417252</phone>
      <phone_ext>402</phone_ext>
      <email>bansal.drvandana@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ashwani K Bansal, MS</last_name>
      <phone>+91-0532-2417252</phone>
      <phone_ext>403</phone_ext>
      <email>arpitivf@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Vandana Bansal, MS DGO PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2013</study_first_submitted>
  <study_first_submitted_qc>August 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2013</study_first_posted>
  <last_update_submitted>August 15, 2013</last_update_submitted>
  <last_update_submitted_qc>August 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Jeevan Jyoti Hospital</investigator_affiliation>
    <investigator_full_name>Dr.Vandana Bansal</investigator_full_name>
    <investigator_title>Director &amp; Consultant</investigator_title>
  </responsible_party>
  <keyword>IVF failure, implantation rate, heparin &amp; aspirin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
    <mesh_term>Dalteparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

